Related Experiment Video
Updated: Jun 28, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients
J Y Lee1, M A Chiong, S C Estrada
1Metabolic Services, Genetic Health Services Victoria, Royal Children's Hospital, Melbourne, Australia.
Abstract:
Maple syrup urine disease (MSUD) is a very rare disorder of branched-chain amino acid metabolism. However, it is the most common inborn error of metabolism in the Philippines. We present a retrospective review of 21 patients diagnosed with MSUD between 1999 and 2004. The patients presented clinically between 2 and 14 days of life (mean 5 days) and the diagnosis of MSUD was established between 6 days and 11 months of age (mean 39 days). The classical burnt sugar odour was noted in the majority of patients (81%). The diagnosis of MSUD was initially based on clinical suspicion and confirmed biochemically by measurement of leucine/isoleucine levels by thin-layer chromatography. The acute management included removal of accumulated branched-chain amino acids by peritoneal dialysis in 62% of the patients. Mortality rate of this group of patients was 24% and follow-up rate was 87%. We compared this series with a previously reported series of 26 patients to determine whether diagnosis and the management of MSUD improved over the two periods. Four cases have been diagnosed early since 1992, the majority of whom had the classic form of MSUD with the onset of symptoms in the first two weeks of life. A small subset of patients with early nonspecific symptoms was diagnosed much later owing to a low-level clinical suspicion among clinicians. Overall, however, there appears to be a small but general trend towards earlier diagnosis, reduced mortality and long-term follow up in the later series. Although we are able to diagnose and manage MSUD in the Philippines, we recognize that the clinical outcome remains poor and is due mainly to late referral of cases and inadequate long-term management. In the Philippines, we recommend that all newborns who are considered to be septic, have feeding difficulties, fail to regain their birth weight or present with any other symptoms suggestive of MSUD be evaluated in the first instance by analysis of urine for ketones and if they are positive have blood collected and sent to our laboratory for leucine/isoleucine measurement.
Insights
Maple syrup urine disease (MSUD) is a rare metabolic disorder. Early diagnosis and improved management in the Philippines show trends toward reduced mortality, but late referrals still impact outcomes.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Maple syrup urine disease (MSUD) is a rare inherited disorder of branched-chain amino acid metabolism.
- It is the most common inborn error of metabolism in the Philippines.
- Despite advances, clinical outcomes for MSUD patients remain poor due to late diagnosis and management.
Purpose of the Study:
- To review the diagnosis and management of 21 MSUD patients in the Philippines between 1999 and 2004.
- To compare these findings with a previous series to assess improvements in diagnosis and care.
- To identify factors contributing to poor clinical outcomes and recommend improvements.
Main Methods:
- Retrospective review of 21 MSUD patients diagnosed between 1999 and 2004.
- Clinical presentation, diagnosis methods (clinical suspicion, urine/blood tests), and acute management (peritoneal dialysis) were analyzed.
- Comparison with a historical cohort of 26 patients diagnosed since 1992.
Main Results:
- Patients presented between 2-14 days of life, diagnosed by a mean of 39 days.
- Classical 'burnt sugar' odor noted in 81% of patients.
- Mortality rate was 24%, with a trend towards earlier diagnosis and reduced mortality in the later series.
Conclusions:
- While diagnosis and management capabilities exist in the Philippines, late referrals and inadequate long-term care hinder optimal outcomes.
- Early detection through newborn screening for suggestive symptoms (sepsis, feeding difficulties) is crucial.
- Prompt biochemical analysis (urine ketones, blood leucine/isoleucine) is recommended for suspected cases.
More Related Videos
09:28One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
08:30Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents
Published on: January 31, 2020
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Nephrotic Syndrome II : Assessment and Medical Management
Type I Diabetes III: Clinical Manifestations
Urine Studies I: Urinalysis
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Insipidus I: Introduction